BioE News Exchange
Below are stories and publications, ordered by date, by organizations within Alberta's bioindustrial innovation ecosystem, including Alberta Innovates. Also included are articles by media outlets of relevance to Alberta's bioindustry.
This six-page fact sheet summarizes outcomes of the Alberta Innovates funding program, Alberta Bio Future, over the period 2015-19.
This annual report presents a summary of activities and outcomes for the period 2018-19 for the Alberta Innovates funding program, Alberta Bio Future.
One option for reduction is decreasing the use of oil and coal by increasing usage of a lower-carbon fossil fuel -- natural gas.
Researchers in tissue engineering and regenerative medicine have long been interested in creating artificial living human tissue for drug development and disease modeling.
The 2018 legalization of cannabis has opened new opportunities not only for marijuana, but also for its cousin, industrial hemp.
These shape memory polymer-CNC stents could be inserted in a heart valve in a closed position. The stent would open fully when warmed with body heat.
Health clinicians may soon have a new and effective bioimaging tool to produce in-depth personal medical reports based on a patient's genetics or to better diagnose presence of some diseases like hepatitis C and cancer.
Research done at the University of Alberta has found that this "slime" can be put to good use in the oil sands industry, both to help produce renewable energy and to reduce the industry's carbon footprint.
This final report presents outcomes from the Alberta Innovates funding program, Advanced Materials and Chemicals (AMCP), which was active 2010-18.
This annual report presents a summary of activities and outcomes for the period 2017-18 for the Alberta Innovates funding program, Alberta Bio Future.
Researchers at Hexion Canada's forest products R&D lab in Edmonton are developing ways to create new bio-based adhesives that incorporate lignin, a sticky compound in trees and a byproduct of the kraft pulping process.
These Ceapro ingredients are highly prized by well-known international healthcare and cosmetic manufacturers for adding to products like Aveeno®, Dove®, Neutrogena®, Burt's Bees®, The Body Shop® and Bath & Body.
Radient Technologies can supply international pharmaceutical, nutraceutical, functional food and cosmetic companies with high-value ingredients for formulation into other products.
TerraVerdae BioWorks Inc. has developed a process that can produce commercial-scale quantities of high-end, biodegradable green plastic and bio-based chemicals.
A group of researchers at the University of Calgary is developing a new way to curb the spread of bacteria causing these problems with a product derived from wood called cellulose nanocrystals (CNC).
An Edmonton biofuel company is a big step closer to commercializing its process for production of renewable, drop-in transportation fuels. Alberta Innovates played a key role in supporting this disruptive technology invented